Felix Baker

Director, 10% owner, Kymera Therapeutics, Inc.; 10% owner, Entrada Therapeutics, Inc.

Bought, 12 months

$173M

Sold, 12 months

$0.0M

Companies

Latest trade

Dec 11, 2025

Companies

Kymera Therapeutics, Inc.Director, 10% owner +$172M Entrada Therapeutics, Inc.10% owner +$0.3M

Trades

KYMR Bought 2,005,813 shares at $86.00 $172M Dec 11

TRDA Bought 28,867 shares at $9.07 $0.3M Nov 20

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.